Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.
Punctual mutations in the TEM-1 or TEM-2 gene may lead to inhibitor-resistant-TEM (IRT) beta-lactamases with resistance to beta-lactam-beta-lactamase inhibitor combinations and susceptibility to cephalosporins. The aim of this work was to analyze the current epidemiology of IRT beta-lactamases in contemporary clinical Escherichia coli. Isolates were prospectively collected in our hospital (2007 and 2008) from both outpatients (59.8%) and hospitalized patients (40.2%). The genetic relationships of the isolates were determined by XbaI pulsed-field gel electrophoresis, multilocus sequence typing, and phylogenetic group analysis. IRT genes were sequenced and located by hybridization, and the incompatibility group of the plasmids was determined. From a total of 3,556 E. coli isolates recovered during the study period, 152 (4.3%) showed reduced susceptibility to amoxicillin-clavulanate, with 18 of them producing IRT enzymes (0.5%). These were mostly recovered from urine (77.8%). A high degree of IRT diversity was detected (TEM-30, -32, -33, -34, -36, -37, -40, and -54), and the isolates were clonally unrelated but were mostly associated with phylogenetic group B2 (55.5%). In 12 out of 16 (75%) isolates, the bla(IRT) gene was plasmid located and transferred by conjugation in 9 of them, whereas chromosomal localization was demonstrated in 4 isolates (25%). The sizes of the plasmids ranged from 40 kb (IncN) to 100 kb (IncFII, IncFI/FIIA), and they showed different restriction patterns by restriction fragment length polymorphism analysis. Unlike extended-spectrum beta-lactamase producers, the frequency of IRT producers remains low in both community and hospital settings, with most of them causing urinary tract infections. Although bla(IRT) genes are mainly associated with plasmids, they can be also located in the chromosome. Despite this situation, clonal expansion and/or gene dispersion was not observed, denoting the independent emergence of these enzymes.
Martín
Oihane
O
Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Valverde
Aránzazu
A
Morosini
María I
MI
Rodríguez-Domínguez
Mario
M
Rodríguez-Baños
Mercedes
M
Coque
Teresa M
TM
Cantón
Rafael
R
del Campo
Rosa
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000453:epidemiology / Q000382:microbiology; D029968:Escherichia coli Proteins / Q000235:genetics*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010802:Phylogeny; D010957:Plasmids / Q000235:genetics; D017422:Sequence Analysis, DNA; D013030:Spain / Q000453:epidemiology; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics*; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D047090:beta-Lactams; D001618:beta-Lactamases
J Clin Microbiol. 2003 Jul;41(7):3035-42
12843039
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6874-8
8341713
J Clin Microbiol. 2000 Apr;38(4):1339-46
10747104
Appl Environ Microbiol. 2000 Oct;66(10):4555-8
11010916
Clin Microbiol Rev. 1995 Oct;8(4):557-84
8665470
Antimicrob Agents Chemother. 2002 Dec;46(12):3991-4
12435708
Microbiology (Reading). 2005 Apr;151(Pt 4):1095-1111
15817778
Antimicrob Agents Chemother. 2009 Jan;53(1):327-8
19001117
Antimicrob Agents Chemother. 1999 Apr;43(4):862-7
10103192
Methods Mol Biol. 1995;46:225-36
7550711
J Clin Microbiol. 2008 Mar;46(3):1076-80
18199778
J Microbiol Methods. 2005 Dec;63(3):219-28
15935499
J Clin Microbiol. 2009 Nov;47(11):3721-5
19710261
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:53-62
18154528
Int J Antimicrob Agents. 2009 Aug;34(2):173-6
19464856
Antimicrob Agents Chemother. 2009 Jun;53(6):2283-8
19364861
J Antimicrob Chemother. 2009 Jun;63(6):1135-41
19351692
Anal Biochem. 1995 Apr 10;226(2):235-40
7793624
Antimicrob Agents Chemother. 2009 Jul;53(7):2846-51
19380595
J Antimicrob Chemother. 2009 Jan;63(1):67-71
18931389
J Bacteriol. 2010 Feb;192(4):1165-6
20008064
J Antimicrob Chemother. 1999 Apr;43(4):447-58
10350372
Antimicrob Agents Chemother. 2009 Oct;53(10):4472-82
19687243
J Antimicrob Chemother. 2008 Aug;62(2):284-8
18453527
J Clin Microbiol. 2008 Dec;46(12):3900-5
18842941
Emerg Infect Dis. 2005 Jun;11(6):954-6
15963296
Antimicrob Agents Chemother. 2007 Feb;51(2):796-9
17145793
Plasmid. 2010 Jan;63(1):53-60
19887083